Novavax shares surge 19% following FDA’s decision



Novavax Inc. shares were up over 19% in the premarket session of Wednesday following the Food and Drug Administration’s (FDA) decision to authorize its COVID-19 vaccine for use in the US.

Earlier…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento